Find clinical trials for Prostate Cancer in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Hanyang, Seoul, KOR:
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...
Phase 1, Phase 2
Seoul, South Korea and 50 other locations
8 weeks (±2 weeks) to patients with metastatic castration resistant prostate cancer (mCRPC) in order to assess the safety and effic...
Phase 2
Seoul, Korea, Republic of
This study is being conducted to learn more about the safety, tolerability, and effectiveness of an experimental treatment for metastatic prostate...
Phase 1, Phase 2
Seoul, South Korea and 12 other locations
The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...
Phase 1
Seoul, South Korea and 54 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Seoul, Korea, Republic of and 131 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Seoul, South Korea and 194 other locations
(control) in participants with metastatic Castration Resistant Prostate Cancer (mCRPC) with prior exposure to at least 1 Androgen R...
Phase 2
Seoul, South Korea and 10 other locations
A phase 3, multi-center, single-group, open-label study to evaluate the efficacy and safety of DKF-MA102 in patients with prostate cancer...
Phase 3
Seoul, Korea, Republic of
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 112 other locations
or enzalutamide) in participants with metastatic Hormone Sensitive Prostate Cancer (mHSPC) and to select the recommended dose of th...
Phase 2
Seoul, South Korea and 16 other locations
Clinical trials
Research sites
Resources
Legal